Product Reports Resources Pricing Login Book a demo

Touchlight Genetics

Biotech & Life Sciences · London, United Kingdom · Founded 2007

Develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases

Valuation $1–2.5B
Revenue $10–50M
Headcount 100–500
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Touchlight Genetics and the history behind them.
Power Law Unicorn$1–10B valuation tier
Knowledge graph
Market map Defence, Security and Resilience startups in Europe Market map UK Techbio landscape

Talent graph

Touchlight Genetics's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Touchlight Genetics's cap table

Sourced from Dealroom's funding and investor records.

Series A 1 investor entered at this stage
Downing Ventures
Series B+ 3 investors entered at this stage
Bridford Group
Novator
Bridford Investments

Ownership

Who owns Touchlight Genetics

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

22% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where Touchlight Genetics has talent and traffic

Workforce by country
8 countries with
team presence
🇬🇧 United Kingdom91.9%
🇺🇸 United States4.5%
🇮🇪 Ireland0.7%
🇦🇪 United Arab Emirates0.7%
🇫🇷 France0.7%
Top 5 of 8 shown
Web traffic by country
4.4K monthly visits
across markets
🇺🇸 United States38.6%
🇬🇧 United Kingdom31.8%
🇮🇳 India22.7%
🇫🇷 France4.5%
Top 4 markets shown

Patent intelligence

$27M patent portfolio · 15 active families

Estimated portfolio value
$27M
2.7% of valuation · 5.6× smaller than top peer Cellectis ($152M)
15 active patent families
Where Touchlight Genetics innovates A-DNACell freeDna templateNucleotideBioinformatics

Where Touchlight Genetics concentrates vs peers

Each axis is a top-10 topic across Touchlight Genetics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Touchlight Genetics

An AI-synthesized read of the highest-engagement posts about Touchlight Genetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Touchlight Genetics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles